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Cross-Sectional Computed Tomographic Assessment
Improves Accuracy of Aortic Annular Sizing for
Transcatheter Aortic Valve Replacement and Reduces
the Incidence of Paravalvular Aortic Regurgitation
Hasan Jilaihawi, BSC (HONS), MBCHB,* Mohammad Kashif, MD,* Gregory Fontana, MD,†
Azusa Furugen, MD, PHD,* Takahiro Shiota, MD,* Gerald Friede, BS, MS,* Rakhee Makhija, MD,*
Niraj Doctor, MBBS,* Martin B. Leon, MD,‡ Raj R. Makkar, MD*
Los Angeles, California; and New York, New York
Objectives In an effort to define the gold standard for annular sizing for transcatheter aortic valve replacement (TAVR), we
sought to critically analyze and compare the predictive value of multiple measures of the aortic annulus for post-
TAVR paravalvular (PV) regurgitation and then assess the impact of a novel cross-sectional computed tomo-
graphic (CT) approach to annular sizing.
Background Recent studies have shown clear discrepancies between conventional 2-dimensional (2D) echocardiographic and
CT measurements. In terms of aortic annular measurement for TAVR, such findings have lacked the outcome
analysis required to inform clinical practice.
Methods The discriminatory value of multiple CT annular measures for post-TAVR PV aortic regurgitation was compared
with 2D echocardiographic measures. TAVR outcomes with device selection according to aortic annular sizing
using a traditional 2D transesophageal echocardiography–guided or a novel CT-guided approach were also studied.
Results In receiver-operating characteristic models, cross-sectional CT parameters had the highest discriminatory
value for post-TAVR PV regurgitation: This was with the area under the curve for [maximal cross-sectional
diameter minus prosthesis size] of 0.82 (95% confidence interval: 0.69 to 0.94; p  0.001) and that for
[circumference-derived cross-sectional diameter minus prosthesis size] of 0.81 (95% confidence interval:
0.7 to 0.94; p  0.001). In contrast, traditional echocardiographic measures were nondiscriminatory in re-
lation to post-TAVR PV aortic regurgitation. The prospective application of a CT-guided annular sizing ap-
proach resulted in less PV aortic regurgitation of grade worse than mild after TAVR (7.5% vs. 21.9%;
p  0.045).
Conclusions Our data lend strong support to 3-dimensional cross-sectional measures, using CT as the new gold standard for
aortic annular evaluation for TAVR with the Edwards SAPIEN device. (J Am Coll Cardiol 2012;59:1275–86)
© 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.11.045Transcatheter aortic valve replacement (TAVR) with the
Edwards SAPIEN device (Edwards Lifesciences, Irvine, Cal-
ifornia) has been shown to improve survival in nonoperative
candidates (1) and to have equivalent survival outcomes to
urgery in high-risk patients (2). Recent evidence suggests that
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Aortic Annular Cross-Sectional CT for TAVR Sizing April 3, 2012:1275–86trial, a significantly higher figure
than for the surgical group (0.9%)
(2). Inappropriate sizing is likely to
be a major mechanism of PV AR.
There is a growing appreciation
that 2-dimensional (2D) echocar-
diography fails to appreciate the
noncircular geometry of the aortic
annulus (Fig. 1) and that com-
puted tomography (CT), as a
3-dimensional assessment, appears
superior in this respect (5). There
are discrepancies between conven-
tional 2D echocardiographic and
CT measurements (6,7). In an ef-
fort to determine whether CT
should be the gold standard for
aortic annular assessment, the ob-
jectives of the current study were
2-fold: 1) to retrospectively analyze
CT dimensions in patients who
had undergone transesophageal
echocardiography (TEE)–guided
TAVR and to compare the predic-
tive value of multiple measures of
the aortic annulus for post-TAVR
V regurgitation; and 2) to assess the impact on post-TAVR PV
R of a prospective application of CT annular measurements to
hoice of bioprosthesis size.
ethods
atient population and study design. All patients were
nrolled by a single center to the U.S. PARTNER trial. Patients
ith electrocardiogram (ECG)-gated contrast CT data, studied
etrospectively, had a traditional TEE approach to aortic annular
izing. There was a later expansion of the study, after application
f a CT annular sizing model derived from the retrospective
nalysis. A multivariable analysis for the predictors of PV regur-
itation in those with available contrast CT studies was applied to
he entire study population. These constituted consecutive patients
ith available systolic-phase contrast CT studies.
atient assessment and procedure. Although a baseline
horacic CT study was performed at the outset, this was
rimarily to evaluate root geometry, aortic disease, and
alcification and was not used for annular sizing before this
nalysis. The CT specialist only performed the protocol
CG-gated cardiac contrast study if the renal function was
onsidered satisfactory, as is routine clinical practice; only
hese patients were included in this study. The procedure
as performed under general anesthesia with combined
EE and fluoroscopic guidance (1).
ulti-slice CT image acquisition and preliminary image
nalysis. An ECG-gated, multi-slice CT angiography
tudy was performed pre-procedure with a Siemens Soma-
Abbreviations
and Acronyms
AR  aortic regurgitation
CI  confidence interval
CMPR  curved
multiplanar reconstruction
CT  computed
tomography
ECG  electrocardiogram
LVEF  left ventricular
ejection fraction
LVOT  left ventricular
outflow tract
NYHA  New York Heart
Association
PV  paravalvular
ROC  receiver-operating
characteristic
TAVR  transcatheter
aortic valve replacement
TEE  transesophageal
echocardiography
TTE  transthoracic
echocardiographyom Cardiac 64 scanner (Siemens Medical Solutions USA, rnc., Malvern, Pennsylvania), using collimation of 0.6 mm
t a fixed pitch of 0.2 with an injection of 110 ml of Isovue
70 (Bracco Diagnostics Inc., Princeton, New Jersey). A
edicated protocol was formulated, with 120 kV and tube
urrent modified according to patient size. A standard
onvolution kernel of B35f was applied with a gantry
otation time of 330 ms. The ECG at the time of acquisi-
ion was reviewed before reconstruction to select out ectopy.
Three-dimensional images were reconstructed using
NSIGHT software (Neoimagery Co., City of Industry,
alifornia). For reconstruction of mid-systolic data, the
ine/movie feature of this software was used to determine
he point in the cardiac cycle where the aortic valve was
aximally open. This technique involved starting from 0%
nd going through to 100%, initially moving at 5%, then,
ithin the 5% selected, at 1% increments across the cardiac
ycle. Diastolic images were also reconstructed in mid-
iastole. The cine/movie mode is standard and potentially
vailable from several commercially available CT systems.
Conventional coronal and oblique sagittal (double oblique)
easurements were made in mid-systole. Data were also used
or curved multiplanar reconstructions (CMPRs) by tracing a
ine through the center point of the proximal ascending aorta,
ortic valve, annulus, and left ventricular outflow tract
LVOT). The basal plane was defined as a plane perpendicular
o the CMPR line at the ventricular aspect to where all 3
eaflets could be seen to disappear. This approximated to the
adir of the 3 leaflets and generated an image defined as the
nnular (or “basal”) plane (also termed “ring”) (Fig. 1, denoted
y ellipsoid joining 3 stars).
ulti-slice CT image analysis. Calibrated images from
asal ring CMPRs generated using INSIGHT were ex-
orted to Osirix (Geneva, Switzerland). A polygonal line
ircumscribing this basal ring was traced to determine its
rea and perimeter. Nonorthogonal true maximal (Dmax)
and true minimal (Dmin) dimensions through the center
oint were determined electronically using this software.
he Dmean was determined as the average of these 2 values.
Given the placement of a bioprosthesis with an expected
circular cross-section, Dcirc was calculated as: [(perimeter of
the traced polygon)/] and Darea as: [2  (area of traced
polygon in mm2/)], as has been previously proposed (8)
Figs. 1 and 2).
Data from 20 randomly selected patients from the retro-
pective (n  81) cohort were compared with CMPR
nalyses using software specifically customized to valve
nalysis (3mensio Valves, version 4.1, 3mensio Medical
maging BV, Bilthoven, the Netherlands). This cohort was
nalyzed in both mid-systolic and diastolic phases.
alcium severity index and calcium asymmetry index.
NSIGHT was used for analysis of leaflet and LVOT
alcium. Using maximal intensity projection, a slab perpen-
icular to the plane of the LVOT was generated with
hickness from nadir to tips of the leaflets in mid-systole.
ach leaflet was scored individually from 0 to 3, with 0epresenting no calcium, 1 mildly calcified, 2 moderately
1277JACC Vol. 59, No. 14, 2012 Jilaihawi et al.
April 3, 2012:1275–86 Aortic Annular Cross-Sectional CT for TAVR SizingFigure 1 Anatomic, Computed Tomography, and Echocardiographic Correlations of the Aortic Root
In the trifoliate aortic valve, the aortic root and its 3 leaflets form a complex 3-dimensional structure (top panel, adapted from H. Gray. Anatomy of the Human Body. Phil-
adelphia, PA: Lea & Febiger, 1918), which is incompletely appreciated by conventional 2-dimensional echocardiographic imaging (bottom panel, intra-procedural trans-
esophageal echocardiography [TEE]). Leaflet hinge points seen on 2-dimensional images (bottom panel) represent the interface of the leaflet and the left ventricular wall
at either the nadir of the leaflet (asterisks) or at a point (white circle) that is a highly variable distance (z) above the basal plane (top, middle, and bottom panels). The
TEE beam (blue triangle) represents a linear beam that images the aortic annulus posteriorly from the perspective of the left atrium. Often this cuts the basal plane
obliquely, but even when through the center of the basal ring, it is impossible to determine the relationship of this cut to the true major and minor axis of the aortic
basal ring (center panel).
L
E
w
C
t
t
2
a
w
T
v
r
D
u
fi
w
d
i
a
c
1278 Jilaihawi et al. JACC Vol. 59, No. 14, 2012
Aortic Annular Cross-Sectional CT for TAVR Sizing April 3, 2012:1275–86calcified, and 3 severely calcified. Overall valvular calcium
severity index was graded between 0 and 9 on the basis of
the sum of the individual leaflet scores. A calcium asymme-
try index was graded on the basis of the difference between
adjacent leaflet calcium scores and the sum of the 3 differences.
VOT calcium was graded separately from 0 to 3.
chocardiography. For the purposes of the procedure,
annular size was confirmed using intra-procedural TEE
measurements with a zoomed long-axis mid-systolic frame
hinge point to hinge point measurement. Specifically, the
protocol required annuli of 18 to 25 mm. Traditional cutoffs
for annular size by TEE mandate that patients with annuli
of 18 to 21 mm are prescribed a 23-mm prosthesis, and
those with annuli of 22 to 25 mm are prescribed a 26-mm
prosthesis. Patients with annuli of 21 to 22 mm receive either
prosthesis, at the discretion of the treating physician. Pre-
procedural transthoracic echocardiography (TTE) annular di-
mensions were those measured prospectively. Intraprocedural
TEE annular dimensions included in the analysis were both a
long-axis measurement used for the choice of prosthesis size by
an expert clinician echocardiographer (DTEE), as well as the
largest peri-procedurally recorded long-axis TEE measure-
ment (DTEE(MAX)).
Post-TAVR bioprosthetic dysfunction was assessed in line
ith guidelines suggested by the Valve Academic Research
onsortium (9). For the assessment of bioprosthetic regurgi-
ation and device positioning, peri-procedural TEE examina-
ions were reviewed retrospectively. This was performed by 1 of
physician readers with more than 4 years of experience in the
ssessment of TAVR echocardiograms who were not involved
Figure 2 Dynamic Changes in the Aortic Annulus Cross-Section
(A) Systole and (B) diastole. The aortic annulus is less elliptical in systole, and it
whereas its minimal/minor dimensions show more variation.ith the procedure and were blinded to the peri-procedural
DEE report, CT images, and clinical and angiographic data. In
iew of a tendency to underestimate PV regurgitation, any
egurgitation more than mild was regarded as significant.
oppler assessment of stenotic physiology was performed
sing pre-discharge TTE.
We accounted for malpositioning through an analysis of
nal device position by TEE using the long-axis view. This
as device depth below the annulus, as measured by the
istance of the lowest part of the stent frame below the
nterface of the noncoronary sinus and aortic-mitral conti-
CT-Determined Cross-Sectional AorticAnnular Dimensions Compared in Systolea d Diastol in 20 Randomly Selectedases F o the Original 2D TEE-Guid Cohort
Table 1
CT-Determined Cross-Sectional Aortic
Annular Dimensions Compared in Systole
and Diastole in 20 Randomly Selected
Cases From the Original 2D TEE-Guided Cohort
Systole (n  20)
(Mean Phase
15.9  7.0%)
Diastole (n  20)
(Mean Phase
64.2  4.3%) p Value
Dcirc, mm 24.7 2.5 23.8 2.4 0.001
Darea 24.0 2.5 22.9 2.4 0.001
Dmax 27.1 2.9 26.8 2.8 0.43
Dmin 21.3 2.7 19.7 2.3 0.001
Dmajor 26.9 2.7 26.8 2.8 0.66
Dminor 21.5 2.7 19.9 2.2 0.001
Dmean 24.2 2.6 23.3 2.3 0.001
Dmax/Dmin 1.27 1.0 1.37 0.12 0.005
Dmajor/Dminor 1.26 0.11 1.35 0.12 0.001
Values are mean  SD.
CT  computed tomography; Darea  annular diameter derived from cross-sectional area; Dcirc 
nnular diameter derived from cross-sectional circumference; Dmajor annular diameter derived from
orthogonal major axis cross-sectional diameter; Dmax  annular diameter derived from maximal
ross-sectional diameter; Dmin  annular diameter derived from minimal cross-sectional diameter;
orphology
imal/major dimensions are relatively consistent throughout the cardiac cycle,al M
s maxminor  annular diameter derived from orthogonal minor axis diameter; TEE  transesophageal
echocardiography.
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April 3, 2012:1275–86 Aortic Annular Cross-Sectional CT for TAVR Sizingnuity. A final device depth of 60% of the stent frame
length (corresponding to the covered skirt) below the
annulus was regarded as low malpositioning, with high
malpositioning defined as the lowest part of the stent frame
above the aortic annulus.
Clinical endpoints. Clinical endpoints related to device
sizing included need for emergent valve-in-valve, annular
rupture, evidence of prosthesis instability, and peri-
procedural mortality.
Statistical analysis. Statistical analyses were made using
SPSS software (PASW version 18, SPSS Inc., Chicago,
Illinois) and SAS version 9.2 (SAS Institute, Cary, North
Carolina). Normality of distributions for continuous vari-
ables was tested using the Shapiro-Wilks test, and data were
Receiver-Operating Characteristic Curve Analysis forAortic Annulus With Post-TAVR Paravalvular RegurgTable 2 Receiver-Operating Ch racteristic C veAortic Annulus With Post-TAVR Paraval
Variable Area Under
CT parameters
 Dcirc  (Dcirc – TAVR size) 0.8
 Darea  (Darea–TAVR size) 0.7
 Dmax  (Dmax–TAVR size) 0.8
 Dmin  (Dmin–TAVR size) 0.6
 Dmean  (Dmean–TAVR size) 0.7
 Dcoronal  (Dcoronal–TAVR size) 0.6
 DOS  (DOS–TAVR size) 0.6
Echocardiographic parameters
 DTTE  (DTTE–TAVR size) 0.4
 DTEE  (DTEE–TAVR size) 0.5
 DTEE(MAX)  (DTEE(MAX)–TAVR size) 0.6
  delta; CI  confidence interval; Dcoronal  annular diameter der
saggital diameter; DTTE  annular diameter derived from transthoraci
echocardiography; TAVR  transcatheter aortic valve replacement. Ot
Clinical DataTable 3 Clinical Data
All Studied Patients
(n  136)
Age, yrs 84.2 8.2
Female 68 (50)
Diabetes 39 (29.1)
Hypertension 117 (87.3)
Prior PCI 48 (35.8)
Prior CABG 54 (39.7)
Prior BAV 25 (18.7)
Prior stroke 30 (22.4)
Baseline renal disease (creatinine 2 mg/dl) 9 (6.7)
Pulmonary disease 76 (56.7)
Porcelain aorta 4 (3)
STS-PROM score 10.3 3.4
Logistic EuroSCORE 30.3 15.7
Frailty 25 (18.5)
Height, cm 164 11
Weight, kg 70.7 16.8
BSA, cm2/m2 1.8 0.2
Values are mean  SD or n (%).
BAV  balloon aortic valvuloplasty; BSA  body surface area; CABG  coronary artery bypass graftin
TS-PROM  Society of Thoracic Surgeons Predicted Risk of Mortality; TEE  transesophageal echocardanalyzed appropriately thereafter. Paired data were assessed
using a paired t test for normally distributed variables and a
Wilcoxon signed rank test for non-normally distributed
variables. A chi-square test was used for categorical variables
compared across independent groups. For normally distrib-
uted continuous variables compared across independent
groups, an independent samples t test was used. For
on-normally distributed continuous variables compared
cross independent groups, a Mann-Whitney U test was
sed.
Receiver-operating characteristic (ROC) curves were
enerated using post-TAVR PV AR  mild as the event.
reas under the curve were compared for measures derived
rom traditional TEE sizing and novel CT measures using
iple Baseline Measures of the>Mild as the Outcome Measurelysis for Mul ipl Bas line asures of the
Regurgitation >Mild as the Outcome Measure
urve SE p Value 95% CI
0.063 0.001 0.69–0.94
0.072 0.001 0.64–0.92
0.062 0.001 0.70–0.94
0.079 0.029 0.52–0.83
0.066 0.001 0.65–0.91
0.083 0.061 0.49–0.81
0.083 0.088 0.47–0.80
0.086 0.94 0.33–0.66
0.08 0.67 0.37–0.70
0.09 0.087 0.46–0.81
m coronal diameter; DOS  annular diameter derived from oblique
ardiography; DTEE  annular diameter derived from transesophageal
reviations as in Table 1.
2D TEE-Guided
Annular Sizing
(n  96)
Cross-Sectional CT-Guided
Annular Sizing
(n  40) p Value
84.9 7.2 82.4 10.2 0.17
46 (47.9) 22 (55) 0.45
26 (27.7) 13 (32.5) 0.57
80 (85.1) 37 (92.5) 0.24
36 (38.3) 12 (30.0) 0.36
36 (37.5) 18 (45) 0.42
17 (18.1) 8 (20) 0.80
19 (20.2) 11 (27.5) 0.35
7 (7.4) 2 (5) 0.61
56 (59.6) 20 (50) 0.31
2 (2.1) 2 (5) 0.37
10.6 2.9 9.8 4.5 0.22
31.2 16.1 27.5 14.5 0.24
16 (16.8) 9 (22.5) 0.44
164 11 164 11 0.72
69.1 15.9 74.5 18.4 0.11
1.7 0.2 1.8 0.2 0.28MultitationAna
vular
the C
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ived frog; CT  computed tomography; 2D  2-dimensional; PCI  percutaneous coronary intervention;
iography.
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defined using these curves on the basis of the highest sum of
the sensitivity and specificity for the prediction of PV
AR  mild. Cross-sectional annular CT-derived cutoffs
defined by this analysis were later applied to a prospectively
treated population and outcomes compared with a tradi-
tional TEE-based annular sizing approach. For the entire
population studied, candidate baseline and procedural fac-
tors related to post-TAVR PV AR were evaluated in a
binary logistic regression model. Variables found to be
significant to p  0.1 were entered into an exploratory
multivariable binary logistic regression model for AR  mild.
Results
Study population. From a series of 192 consecutive patients
scheduled for TAVR between January 2008 and March 2011,
ECG-gated contrast thoracic scans were available in 81 patients;
a randomly selected 20-patient subset was compared in systole and
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(A) D . (B) D . (C) D . (D) D . CT  computed tomography; ROC circ max TTE TEEdiastole (Table 1). The 81-patient cohort was analyzed retrospec-
tively for the predictive value of multimodality annular measures
for post-TAVR PV leak (Table 2). Baseline clinical characteristics
were analyzed with the subsequently expanded TEE-guided
annular sizing cohort (Table 3).
Reliability assessment of native aortic annular dimensions and
post-TAVR PV leak. CT measurements for the main study
were made in systole, where maximal opening of the aortic
valve was seen. In repeated reconstructions from raw Digital
Imaging and Communications in Medicine (DICOM) data
for the subset of 20 randomly selected patients previously
described, intra observer variability was 0.53  0.54 mm for
Dcirc measurements (paired sample correlation r  0.98, p 
.001) and 0.27  0.89 mm (paired sample correlation r 
.95, p  0.001) for Dmax measurements. Inter-observer
ariability was 0.07 0.87 mm for Dcirc measurements (paired
sample correlation r  0.94, p  0.001) and 0.67  1.19 mm
or Dmax measurements (paired sample correlation r  0.92,
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April 3, 2012:1275–86 Aortic Annular Cross-Sectional CT for TAVR Sizingp  0.001). With regard to intra-observer agreement for the
ssessment of significant PV regurgitation, the kappa statistic
as 0.77 (p  0.001), and for inter-observer agreement, the
appa was also 0.77 (p  0.001).
There was a significant variation throughout the cardiac
ycle for all CT-derived measurements, which were gener-
lly larger in systole (Table 1). The lower ratios of Dmax/
min and Dmajor/Dminor in systole were consistent, with a
less elliptical and more circular morphology of the aortic
annulus in systole than in diastole.
ROC curve analyses and the prediction of PV regurgitation.
Multiple CT and echocardiographic annular measurement
parameters were evaluated for their predictive value for PV
regurgitationmild in the original retrospective 81-patient
cohort (Table 2). Dmax (Dmax minus TAVR size) and
Dcirc (Dcirc minus TAVR size) were of greatest discrimi-
natory value (Table 2, Figs. 3 and 4). Echocardiographic
and CT coronal and oblique sagittal measurements were
nondiscriminatory. Comparing DTEE, derived from the
traditional TEE measurement (used for the decision for
prosthesis size for the retrospective cohort), with Dmax and
Dcirc, measurements derived from the novel CT method-
logy of sizing yielded significant differences, with p 
.004 for Dmax versus DTEE and p  0.003 for Dcirc
versus DTEE. The discriminatory value of CT parameters
Figure 4
Superimposed ROC Curves Evaluating Predictive
Value of Cross-Sectional CT and Standard
Echocardiographic Measurements for
Post-TAVR Paravalvular Regurgitation (> Mild)
The cross-sectional CT-derived parameters (Dcirc and Dmax) had a consider-
ably greater discriminatory value (with larger areas under the curve) for signifi-
cant paravalvular regurgitation (mild) than 2-dimensional echocardiography-
derived measurements (DTEE (MAX) and DTTE). See Table 2 and text for
further details. Abbreviations as in Figure 3.eld if PV AR  moderate was used as the dichotomous cndpoint (for Dmax: area under the curve 0.82, 95%
confidence interval [CI]: 0.66 to 0.97, p 0.001; for Dcirc:
area under the curve 0.80, 95% CI: 0.66 to 0.95, p 0.001).
Using the coordinates of each curve, Dmax of 4 mm or a
Dcirc of 1.5 mm had the highest sum of sensitivity and
pecificity (Fig. 3).
rospective cross-sectional CT-guided annular sizing
pproach. An additional 15 patients were treated by a TEE-
ased annular sizing approach before the CT-guided approach
as implemented in May 2011. With the 81 patients analyzed
or the initial retrospective ROC curve analysis, this comprised
he 96-patient TEE-guided annular sizing cohort (Table 3).
ubsequently, 40 patients were treated using a cross-sectional
T method of annular sizing. This incorporated an annular
izing approach based on the ROC curve analysis prosthesis
bserving cutoffs of a Dmax of 4 mm and a Dcirc of
1.5 mm. The overall 136-patient cohort with systolic
ontrast CT scans was derived from a total of 270 consec-
tive patients scheduled for TAVR with the Edwards
APIEN device until September 2011. There were no
ifferences in clinical, echocardiographic, and procedural
haracteristics in the patients treated according to either
nnular sizing approach (Tables 3 and 4).
Central aortic regurgitation of grade  moderate was
bserved in only 1 patient (0.73%). Excellent hemodynamic
utcomes (Table 5) were achieved with the cross-sectional
T approach to annular sizing with a significant reduction
n the incidence of PV AR. Only 2 cases of moderate PV
R (5%) occurred after observing the annular sizing proto-
ol dictated by cross-sectional CT. In one of these cases,
here was extremely bulky native leaflet calcification, and in
he other, extensive LVOT calcification.
For the 96-patient TEE-guided sizing cohort, 60 patients
eceived a 23-mm Edwards SAPIEN device, and 36 received
26-mm Edwards SAPIEN device. If our cross-sectional CT
riteria were applied, 26 of 60 patients would have received a
6-mm rather than a 23-mm device, and 17 of 36 would have
ad annuli deemed too large for a 26-mm bioprosthesis. Of
hese 17, 12 could have had a 29-mm device (commercially
vailable in Europe and Canada) if it were available, but 5 of 17
ad annuli that would have been considered too large even for
hat device. Overall, treatment reassignment would have ex-
sted in 43 of 96 patients (44.8%).
Although there was no difference in TTE and TEE
easures of the aortic annulus between TEE-guided and
T-guided sizing approaches, there were significant differ-
nces in many CT parameters, including Dmax, Dmean, Dcirc,
and Darea (Table 4).
rospective CT assessment and exclusion of patients for
AVR. After the change in our practice of aortic annular
ssessment, 3 patients during the time period studied were
ccepted by the PARTNER committee (with aortic annular
imensions based on TTE), but were subsequently rejected
nternally for TAVR. Two additional patients were internally
eclined for TAVR before presentation to the PARTNER
ommittee. These decisions were based on an analysis of their
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30 mm and a Dcirc 27.5 mm). By our present CT criteria,
of 5 of these patients would have been suitable for a 29-mm
dwards SAPIEN bioprosthesis, which is currently unavail-
ble to PARTNER trial investigators.
xploratory multivariable analysis. Candidate clinical,
chocardiographic, CT, and procedural variables were evalu-
ted for their predictive value for significant PV AR ( mild)
n univariate binary logistic regression analysis (Table 6). In the
xploratory stepwise multivariable model for post-TAVR PV
R  mild, only Dmax by CT and presence of LVOT
alcium remained predictive. Dmax and Dcirc were highly
correlated (Pearson r 0.91, p 0.001). Given this collinear-
Baseline Echocardiographic, CT, and Procedural VariablesTable 4 Baseline Echocardiographic, CT, and Procedural Variab
All Studied Patients
(n  136)
Echocardiographic variables
Peak velocity, m/s 4.2 0.9
Mean aortic gradient, mm Hg 44 (41–53)
Concomitant MR 3 15 (12.5)
LVEF, % 59.7 13.9
Baseline AR  3 11 (8.5)
Annular dimensions
TTE, mm 20.4 1.1
TEE, mm 21.7 2.0
TEE (MAX), mm 22.5 2.1
 DTTE  (DTTE–TAVR size) 	3.7 1.2
 DTEE  (DTEE–TAVR size) 	2.4 1.3
 DTEE (MAX)  (DTEE (MAX)–TAVR size) 	1.6 1.6
Computed tomography variables
Annular dimensions, mm
Dcoronal 24.4 2.4
DOS 21.7 2.3
Dmax 27.2 2.9
Dmin 21.3 2.6
Dmean 24.2 2.6
Dcirc 24.7 2.4
Darea 24.0 2.5
 Dmax(Dmax–TAVR size) 3.0 2.4
 Dcirc(Dcirc–TAVR size) 0.5 1.9
Valve calcium severity index 7.75 (6–9)
Valve calcium asymmetry index 2 (0–3)
LVOT calcium score 0.5 (0–2)
Any LVOT calcium 82 (60.3)
Procedural variables
Approach
Transfemoral 114 (83.8)
Transapical 22 (16.2)
Bioprosthesis diameter (mm)
23 83 (61)
26 53 (39)
Malpositioned bioprosthesis 3 (2.3)
Values are mean  SD, n (%), or median (25th to 75th interquartile range).
AR  aortic regurgitation; CT  computed tomography; 2D  2-dimensional; LVEF  left ventr
TTE  transthoracic echocardiography. Other abbreviations as in Table 2.ty, the multivariable model was also run for Dcirc withoutDmax, which yielded only presence of LVOT calcium (mul-
ivariable odds ratio  19.4, 95% CI: 1.7 to 226, p  0.018)
nd Dcirc (multivariable odds ratio per mm Dcirc  1.71,
5% CI: 1.2 to 2.4, p  0.003) as independently predictive of
ignificant PV AR.
ther clinical outcomes. This study was underpowered for
rediction of clinical outcomes. Importantly, annular rupture
esulting in peri-procedural death was seen in 1 patient
Fig. 5). One 26-mm SAPIEN device was seen to rock on
EE, producing variable significant AR (Fig. 6, Online
ideo 1); this patient died from congestive heart failure on
he ninth post-procedural day. The Dmax for this case was
almost 10 mm, but TEE had yielded highly heterogeneous
2D TEE-Guided
Annular Sizing
(n  96)
Cross-Sectional CT-Guided
Annular Sizing
(n  40) p Value
4.2 0.8 4.2 1.2 0.92
43 (40–55) 44.5 (42.0–51.5) 0.47
12 (14.5) 3 (8.1) 0.33
58.9 14.7 61.5 11.8 0.30
10 (10.9) 1 (2.6) 0.13
20.5 1.1 20.2 1.0 0.06
21.7 1.9 21.5 2.1 0.66
22.6 2.2 22.4 2.0 0.59
	3.6 1.2 	4.0 1.2 0.07
	2.4 1.2 	2.6 1.3 0.44
	1.5 1.7 	1.8 1.5 0.30
24.3 2.5 24.7 2.0 0.33
22.0 2.4 21.3 2.5 0.079
27.8 3.0 25.6 2.2 0.001
21.5 2.7 20.8 2.2 0.15
24.7 2.7 23.2 2.1 0.001
25.2 2.5 23.6 1.9 0.001
24.4 2.5 23.0 1.9 0.001
3.7 2.4 1.3 1.6 0.001
1.0 1.9 0.7 1.3 0.001
8 (6–9) 7.5 (6–8.75) 0.46
2 (0.5–3.0) 1 (0–3) 0.13
0.75 (0–1.75) 0.5 (0–2.0) 0.97
59 (61.5) 23 (57.5) 0.67
0.45
79 (82.3) 35 (87.5)
17 (17.7) 5 (12.5)
0.59
60 (62.5) 23 (57.5)
36 (37.5) 17 (42.5)
3 (3.3) 0 0.26
jection fraction; LVOT  left ventricular outflow tract; TEE  transesophageal echocardiography;les
icular emeasures ranging from 21 to 28 mm (Fig. 6).
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This study substantiates hypotheses suggested by several prior
studies, highlighting the putative value of a 3-dimensional
CT-based evaluation of the aortic annulus for TAVR (6,8). Its
central finding is that 3-dimensionally derived cross-sectional
measurements of the aortic annulus are superior to conven-
tional 2D echocardiographic sizing in the discrimination of
patients with PV regurgitation. Importantly, a CT cross-
sectional assessment of the aortic annulus affects device sizing
and patient selection and reduces post-TAVR PV AR. CT
measurements were reproducible and precisely defined using
ECG gating in a dynamic anatomical framework. Notably,
they have provided a scientific basis for device sizing, which is
lacking from previous research (8).
Delgado et al. (11) examined Edwards SAPIEN valve
unction in relation to CT dimensions, but did not use a
ross-sectional evaluation. They found larger baseline annular
oronal and oblique saggital dimensions in patients with
ignificant PV leak, although the discriminatory value of CT
elative to echocardiography was not assessed. Messika-
Comparison of Outcomes Related to Prosthesis Sizing With TEE- anTable 5 Comparison of Outcomes Related to Prosthesis Sizing
Outcomes
All Studied Patients
(n  136)
PV AR
None 41 (30.1)
Trivial or mild 71 (52.2)
Mild-moderate 9 (6.6)
Moderate 12 (8.8)
Moderate-severe 3 (2.2)
Severe
PV AR  mild 24 (17.6)
Need for bail-out valve-in-valve 1 (0.7)
Annular rupture 1 (0.7)
Prosthesis instability (rocking) 1 (0.7)
Peri-procedural mortality 4 (3)
Values are n (%).
AR  aortic regurgitation; CT  computed tomography; 2D  2-dimensional; PV  paravalvula
Multivariable Model Applied to the Overall Cohort (n  136) for PoTable 6 Multivariable Model Applied to the Overall Cohort (n 
Univariate OR 95% CI
Dmax (per mm) 1.60 1.3–2.1
Any LVOT calcium present 5.90 1.7–20.7
Dcirc (per mm) 1.70 1.3–2.2
Aortic valve CSI (per point) 1.50 1.1–2.1
Female sex 0.15 0.05–0.47
BSA (per m2) 8.60 1.3–58.8
Malpositioning 9.90 0.9–101.0
Small prosthesis size 0.47 0.19–1.1
DTEE (per mm) 1.10 0.7–1.5
DTEE (MAX) (per mm) 1.20 0.92–1.60
Baseline AR grade 0.88 0.52–1.47
All variables shown entered into stepwise forward:logistic regression multivariable model.
AR  aortic regurgitation; BSA  body surface area (Dubois calculation); CSI  calcium severity index;
ot entered into model as univariate p  0.1; OR  odds ratio. Other abbreviations as in Table 2.Zeitoun et al. (6) went further to examine end-systolic/mid-
diastolic cross-sectional dimensions of the aortic annulus in
patients referred for TAVR and found clear differences to TEE
dimensions but did not evaluate outcomes. Schultz et al. (8)
valuated end-systolic cross-sectional CT annular dimensions
n patients undergoing TAVR with the CoreValve ReValving
ystem. They compared operator choice of prosthesis size
ased on TEE to that based on various cross-sectional CT
imensions. Dmean and DCSA (Darea) were found to correspond
ost closely to operator choice. However, it was assumed that
he cutoffs for device appropriateness would be the same as for
chocardiography.
This study demonstrates for the first time that CT cross-
ectional annular assessment for TAVR sizing is superior to
D TEE assessment in reducing PV AR. Maximal dimension
Dmax) and measures of average dimension (Dcirc, Dmean, and
Darea) were significantly lower in the CT-guided group as
compared with the TEE-guided group, suggesting more
aggressive sizing in the CT-guided group (Table 4). Im-
portantly, these differences were not apparent on echocardi-
-Guided ApproachesTEE- and CT-Guided Approaches
TEE-Guided
nular Sizing
(n  96)
Cross-Sectional CT-Guided
Annular Sizing
(n  40) p Value
0.001
23 (24) 18 (45)
52 (54.1) 19 (47.5)
8 (8.3) 1 (2.5)
10 (10.4) 2 (5)
3 (3.1) 0
0 0
21 (21.9) 3 (7.5) 0.045
1 (1) 0 0.52
1 (1) 0 0.52
1 (1) 0 0.52
3 (3.2) 1 (2.5) 0.82
transesophageal echocardiography.
VR Paravalvular Regurgitation > Mild) for Post-TAVR Paravalvular Regurgitation > Mild
p Value Multivariable OR 95% CI p Value
0.001 1.6 1.3–2.0 0.001
0.006 9.1 1.6–50.3 0.021
0.001 Dropped —
0.018 Dropped —
0.001 Dropped — —
0.029 Dropped — —
0.066 Dropped
0.097 Dropped — —
0.73 Not entered
0.18 Not entered
0.62 Not enteredd CTWith
2D
Anst-TA136Dropped  dropped by multivariable model; LVOT  left ventricular outflow tract; Not entered 
0
S
s
H
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o
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sions between sizing strategies, re-iterating the fact that
significant differences are masked if one relies entirely on the
2D analysis of annular dimension. Because malpositioning can
be another reason for PV AR, we also assessed the outcomes
after excluding 3 patients who had high placement in the
TEE-guided cohort. Even with exclusion of these 3 cases, the
reduction of PV AR was significant on the adoption of the
Figure 5 Gross Over-Sizing Based on Echocardiographic Measu
Resulting in Complicated Transcatheter Aortic Valve
(A) Transesophageal echocardiography measurement appeared appropriate for a 2
the procedure. (Ci, Cii) A retrospective evaluation of computed tomography (CT) d
annulus. (Di, Dii) Whether or not the calcium was included in the measurement o
surements as small as 14 to 15 mm.CT-guided approach relative to the TEE sizing cohort (PV sAR: any, 75.3% to 55%; mild-moderate, 7.5% to 2.5%;
moderate, 10.8% to 5%; and moderate-severe, 2.2% to 0%; p
.001).
tudy limitations. This was a single-center retrospective
tudy. The grading of PV regurgitation remains challenging.
owever, the predictive value of cross-sectional CT measures
or PV regurgitation after TAVR remained robust, regardless
f whether  mild or  moderate was regarded as the
nts
cement
Edwards SAPIEN valve. (B) Annular rupture with aortic dissection occurred after
monstrated extensive left ventricular outflow tract calcium extending to the mitral
lar dimension, CT cross-sectional annular assessment revealed well-aligned mea-reme
Repla
3-mm
ata de
f annuignificant endpoint. Only the Edwards SAPIEN valve was
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is at present unproven.
Moreover, the nature of contrast CT imaging with exposure
to both contrast and radiation provides some limitations to
patients with renal impairment and those of younger age. Such
patients may benefit from alternative 3-dimensional imaging of
the cross-section of the aortic annulus, such as magnetic
resonance imaging (12) or 3-dimensional TEE (13). A pub-
lication by Otani et al. (14) compared 3-dimensional TEE
with contrast CT in 71 patients with and 80 without aortic
stenosis and found good correlation between the 2
techniques. Additionally, Ng et al. (5) found that
3-dimensional TEE correlated more strongly with CT
than with 2D TEE. Indeed, it is likely that systematic
3-dimensional echocardiography could overcome some of
the deficiencies in conventional 2D TEE.
Conclusions
The minimization of PV regurgitation is critical before
Figure 6 Gross Under-Sizing Based on Echocardiographic Meas
(Ai to Aiii) Heterogeneous measurements were observed on transesophageal ech
and a rocking valve were observed after transcatheter aortic valve replacement (TA
ments are explained by computed tomography evaluation in the same patient.TAVR can be applied to low surgical-risk populations. Ourdata lend strong support to 3-dimensional cross-sectional
measures, using CT as the new gold standard for aortic
annular evaluation for TAVR with the Edwards SAPIEN
device. We found annular dimensions derived from this
approach to be highly correlated to PV regurgitation, and a
prospective application of this principle significantly re-
duced the incidence of PV AR. The routine application of
such methods in this setting is likely to reduce complica-
tions, and clinical practice should be updated accordingly.
The specific cutoffs used merit validation in larger series.
Enhanced aortic annular sizing will, in turn, also demand
more valve sizes to match native annular dimensions more
precisely, which is likely to lead to a further optimization of
outcomes.
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